Avion Wealth’s Achieve Life Sciences QUIT Stock Holding History

Avion Wealth’s Portfolio QUIT Stock Details QUIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4K	Hold	500	–	–	﹤0.01%	796
2026 Q2	$3K	Hold	500	–	–	﹤0.01%	900
2026 Q1	$1K	Buy	+500	New	+$2.22K	﹤0.01%	952

Other funds holding QUIT

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return

Avion Wealth's QUIT Position: Q3 2026 in Review

Avion Wealth held its Achieve Life Sciences (QUIT) position steady in Q3 2026 at 500 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #796.

Avion Wealth first reported a position in QUIT in Q1 2026 and has held it in 3 quarters since. 42 funds tracked by Wall St. Rank hold QUIT as of Q3 2026.

Avion Wealth held 500 shares of Achieve Life Sciences worth $4K as of Q3 2026.
Avion Wealth left its Achieve Life Sciences share count unchanged in Q3 2026.
Achieve Life Sciences made up ﹤0.01% of Avion Wealth's portfolio in Q3 2026, its #796 holding.
Avion Wealth first reported a position in Achieve Life Sciences in Q1 2026 and has held it in 3 quarters since.
42 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2026.

Based on Avion Wealth's 13F filing for Q3 2026, filed 4 Nov 2026.